A national audit of 1724 post-colonoscopy colorectal cancers: understanding causes and consequences.
1/5 보강
[BACKGROUND] Post-colonoscopy colorectal cancer (PCCRC) represents a potential missed opportunity to diagnose or prevent colorectal cancer (CRC).
- 표본수 (n) 126
APA
Burr N, Beaton D, et al. (2026). A national audit of 1724 post-colonoscopy colorectal cancers: understanding causes and consequences.. Endoscopy, 58(3), 251-261. https://doi.org/10.1055/a-2681-5642
MLA
Burr N, et al.. "A national audit of 1724 post-colonoscopy colorectal cancers: understanding causes and consequences.." Endoscopy, vol. 58, no. 3, 2026, pp. 251-261.
PMID
40789323 ↗
Abstract 한글 요약
[BACKGROUND] Post-colonoscopy colorectal cancer (PCCRC) represents a potential missed opportunity to diagnose or prevent colorectal cancer (CRC). This study aimed to create a standardized, nationwide audit system to determine why PCCRCs occur and to generate evidence to aid prevention.
[METHODS] PCCRCs occurring 6-48 months after colonoscopy were identified from English national datasets and uploaded to a secure portal. The portal contained case review forms based on World Endoscopy Organization (WEO) recommendations for PCCRC review. National Health Service colonoscopy providers (n = 126) were asked to review ≤ 25 PCCRCs. The data were analyzed to determine the characteristics of and reasons for PCCRC.
[RESULTS] Of 2859 PCCRCs, 1724 (60.3 %) were reviewed. Colonoscopies were mostly performed for symptoms (59.2 %) or surveillance (26.5 %). PCCRCs were more common at the hepatic and splenic flexures and transverse colon compared with detected CRCs. PCCRC WEO categorizations were: possible missed lesion, examination adequate 68 %; possible missed lesion, examination inadequate 18 %; detected lesion, not resected 9 %; and likely incompletely resected lesion 5 %. Overall, 69.0 % of PCCRCs were avoidable and 44.2 % led to harm, including premature death in 8.0 %. Non-procedural reasons contributed to 27.1 % of PCCRCs: patient factors 10.2 %; clinical decision making 9.5 %; and administrative factors 7.4 %.
[CONCLUSIONS] This is the largest detailed PCCRC review to date. The majority of PCCRCs were avoidable and caused significant harm. This study clarifies the causes of diagnostic delays and highlights high-risk patients and areas of the colon, and suggests what needs to be done to reduce PCCRC in the future.
[METHODS] PCCRCs occurring 6-48 months after colonoscopy were identified from English national datasets and uploaded to a secure portal. The portal contained case review forms based on World Endoscopy Organization (WEO) recommendations for PCCRC review. National Health Service colonoscopy providers (n = 126) were asked to review ≤ 25 PCCRCs. The data were analyzed to determine the characteristics of and reasons for PCCRC.
[RESULTS] Of 2859 PCCRCs, 1724 (60.3 %) were reviewed. Colonoscopies were mostly performed for symptoms (59.2 %) or surveillance (26.5 %). PCCRCs were more common at the hepatic and splenic flexures and transverse colon compared with detected CRCs. PCCRC WEO categorizations were: possible missed lesion, examination adequate 68 %; possible missed lesion, examination inadequate 18 %; detected lesion, not resected 9 %; and likely incompletely resected lesion 5 %. Overall, 69.0 % of PCCRCs were avoidable and 44.2 % led to harm, including premature death in 8.0 %. Non-procedural reasons contributed to 27.1 % of PCCRCs: patient factors 10.2 %; clinical decision making 9.5 %; and administrative factors 7.4 %.
[CONCLUSIONS] This is the largest detailed PCCRC review to date. The majority of PCCRCs were avoidable and caused significant harm. This study clarifies the causes of diagnostic delays and highlights high-risk patients and areas of the colon, and suggests what needs to be done to reduce PCCRC in the future.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.